FDA Drug Recall Alert – Magnesium Sulfate in Water for Injection, USP 4g/100mL
| Date: | April 01, 2026 |
| From: | Health Plan of San Joaquin/Mountain Valley Health Plan (“Health Plan”) |
| To: | Health Plan Practitioners, Facilities, and Hospitals |
| Type: | Informational/Educational |
| Subject: | Language Resources |
| Business: | Medi-Cal Managed Care/Medicare Dual Special Needs Program (D-SNP) |
On March 24, 2026, the Food and Drug Administration (FDA) released a recall announcement on Magnesium Sulfate in Water for Injection, USP 4g/100mL.
This is for informational purposes only. You may or may not have administered the medication. Please disregard if you have not been affected by this recall.
For the complete details regarding this recall announcement, please visit the following web link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-magnesium-sulfate-water-injection-usp?utm_medium=email&utm_source=govdelivery
Company Announcement
Amneal Pharmaceuticals LLC is voluntarily recalling one lot of Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, to the hospital level. A Magnesium Sulfate in Water for Injection pouch was found to contain an IV bag of Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL.
Affected Product
Magnesium Sulfate in Water for Injection (NDC 70121-1720-3) is indicated for the prevention and control of seizures in preeclampsia and eclampsia. Lot AH250162, is packaged 12 x 100mL pouches to a carton and was distributed nationwide to wholesalers/distributors between 12/22/2025 and 2/27/2026.
What to Do
Amneal is notifying distributors by UPS and is asking for distributors to notify their hospital customers of the product recall. Hospitals that have Magnesium Sulfate in Water for Injection which is being recalled should stop using and return the product to Amneal. Product should be returned to Amneal Pharmaceuticals, Magnesium Sulfate Recall Coordinator, 21 Colonial Drive, Piscataway, NJ 08854.
Contact Information
Hospitals with questions regarding this recall can contact Amneal Pharmaceuticals by:
Phone: 833-582-0812 Monday-Friday, 8:00 am-5:00 pm, EST
Fax: 631-983-2595
E-mail to: MagnesiumSulfateRecall@amneal.com
If you have any further questions, please contact your Provider Services Representative, or call our Customer Service Department at 1-888-936-PLAN (7526). You may also visit https://www.hpsj.com/alerts/ for online access to the documents shared. The most recent information about Health Plan and our services is always available on our website www.hpsj-mvhp.org
